J&J management
This article was originally published in The Tan Sheet
Executive Summary
Worldwide Chairman-Medicines & Nutritionals Christine Poon has been appointed vice chair of Johnson & Johnson, and has been nominated for election to the board of directors at the annual shareholders meeting in April, the firm announces Jan. 12. She will join CEO William Weldon and CFO Robert Daretta in the Office of the Chairman. Poon will report directly to Weldon and continue to oversee all pharmaceutical, consumer pharmaceutical and nutritional businesses. She joined J&J in November 2000 as company group chairman following 15 years at Bristol-Myers Squibb...
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.